Menu
Recruiting NCT07317570

The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders

No phase Interventional Temporomandibular Joint Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Body Awareness Therapy, Standard Physiotherapy.
Who it may be relevant to
Registry conditions: Temporomandibular Joint Disorders. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Randomized, Single-Blind Controlled Trial Investigating the Effect of Body Awareness Therapy on Pain, Functional Outcomes, and Psychosocial Parameters in Adults With Temporomandibular Joint Disorders

Overview

This randomized, single-blind controlled trial aims to investigate the effectiveness of Body Awareness Therapy (BAT) on pain, functional limitations, and psychosocial outcomes in individuals with temporomandibular joint disorders (TMD). TMD is characterized by orofacial pain, impaired jaw function, and increased psychosocial burden, yet current physiotherapy approaches may not fully address the biopsychosocial mechanisms underlying these symptoms. BAT is a structured mind-body physiotherapy intervention designed to improve postural awareness, interoceptive sensitivity, breathing regulation, and movement control. In this study, participants will be randomly assigned to either BAT or a standard physiotherapy control intervention for a defined treatment period. Primary outcomes will include pain intensity and jaw functional limitations, while secondary outcomes will assess body awareness, anxiety, stress, and quality of life. Evaluations will be conducted at baseline and post-intervention. The findings of this trial may provide evidence for integrating biopsychosocial and awareness-based physiotherapy into TMD rehabilitation.

Interventions

  • Behavioral Body Awareness Therapy
    Body Awareness Therapy
  • Other Standard Physiotherapy
    Standard Physiotherapy

Primary outcome measures

  • Jaw Functional Limitation Scale (JFLS) [Time frame: Baseline, post-intervention (8 weeks)]
  • Hospital Anxiety and Depression Scale [Time frame: Baseline, post-intervention (8 weeks)]

Eligibility criteria

Inclusion criteria

Adults aged 18-65 years. Diagnosed with Temporomandibular Joint Disorders (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).

Experiencing orofacial pain or jaw functional limitation for at least the past 3 months.

Ability to understand and follow verbal instructions required for Body Awareness Therapy sessions.

Willingness to participate in the study and to attend all assessment and intervention sessions.

Providing written informed consent.

Exclusion criteria

History of jaw trauma, fracture, or surgery within the past 6 months. Presence of systemic rheumatologic or inflammatory disorders (e.g., rheumatoid arthritis, ankylosing spondylitis) that may affect TMJ function.

Neurological or psychiatric conditions that could interfere with participation or outcome assessments (e.g., major psychiatric disorder, cognitive impairment).

Severe dental or orthodontic conditions requiring immediate treatment (e.g., acute infection, ongoing orthodontic procedures).

Use of occlusal splints, bite guards, or other TMJ-related interventions initiated within the past 3 months.

Participation in any other physiotherapy or exercise program targeting the jaw, cervical spine, or posture during the study period.

Pregnancy, due to potential changes in joint laxity and pain perception. Current use of medications affecting neuromuscular or pain responses, such as muscle relaxants, corticosteroids, or neuropathic pain medications (unless dose has been stable for 3 months).

Any contraindication to performing light-to-moderate physical activity or awareness-based exercises.

Inability to attend scheduled therapy sessions or complete study assessments.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Guneysu Physical Therapy and Rehabilitation School — Rize

Identifiers

NCT: NCT07317570 · 2025/457

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗